Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

T Kuehn, I Bauerfeind, T Fehm, B Fleige… - The lancet …, 2013 - thelancet.com
Background The optimum timing of sentinel-lymph-node biopsy for breast cancer patients
treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) …
被引用次数：1519 相关文章

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective, multicentre cohort study

T Kuehn, I Bauerfeind, T Fehm, B Fleige… - The Lancet …, 2013 - research.uni-luebeck.de
Background: The optimum timing of sentinel-lymph-node biopsy for breast cancer patients
treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) …

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

T Kuehn, I Bauerfeind, T Fehm, B Fleige… - The Lancet …, 2013 - pubmed.ncbi.nlm.nih.gov
Background The optimum timing of sentinel-lymph-node biopsy for breast cancer patients
treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) …

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

T Kuehn, I Bauerfeind, T Fehm, B Fleige… - The Lancet …, 2013 - thelancet.com
Background The optimum timing of sentinel-lymph-node biopsy for breast cancer patients
treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) …

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

T Kuehn, I Bauerfeind, T Fehm, B Fleige… - The Lancet …, 2013 - Elsevier
BACKGROUND: The optimum timing of sentinel-lymph-node biopsy for breast cancer
patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel …

[引用][C] Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

T Kuehn, I Bauerfeind, T Fehm, B Fleige… - The Lancet …, 2013 - cir.nii.ac.jp
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant
chemotherapy (SENTINA): a prospective, multicentre cohort study | CiNii Research CiNii 国立 …

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

T Kuehn, I Bauerfeind, T Fehm, B Fleige… - The Lancet …, 2013 - infona.pl
The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with
neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was …

[引用][C] Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

T Kuehn, I Bauerfeind, T Fehm, B Fleige… - Lancet …, 2013 - ub01.uni-tuebingen.de
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant
chemotherapy (SENTINA): a prospective, multicentre cohort study Sentinel-lymph-node biopsy in …

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.

T Kuehn, I Bauerfeind, T Fehm, B Fleige… - The Lancet …, 2013 - europepmc.org
Background The optimum timing of sentinel-lymph-node biopsy for breast cancer patients
treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) …
[PDF] academia.edu

[PDF][PDF] Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

T Kuehn, I Bauerfeind, T Fehm, B Fleige, M Hausschild… - 2013 - academia.edu
Background The optimum timing of sentinel-lymph-node biopsy for breast cancer patients
treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) …